Synerfuse Revenue and Competitors
Estimated Revenue & Valuation
- Synerfuse's estimated annual revenue is currently $2.8M per year.
- Synerfuse's estimated revenue per employee is $251,000
Employee Data
- Synerfuse has 11 Employees.
- Synerfuse grew their employee count by -8% last year.
Synerfuse's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, President & CEO, Chair the Board Directors | Reveal Email/Phone |
2 | Chief Medical Officer | Board Directors | Reveal Email/Phone |
3 | VP Business Development | Reveal Email/Phone |
4 | VP Intellectual Property | Reveal Email/Phone |
5 | Chief Medical Officer and Chief Regulatory Officer. | Reveal Email/Phone |
6 | Lead Industry Consultant | Reveal Email/Phone |
7 | Executive Administrative Assistant | Reveal Email/Phone |
8 | Executive Administrative Assistant | Reveal Email/Phone |
9 | Strategic Advisor | Reveal Email/Phone |
Synerfuse Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $37.4M | 149 | 4% | N/A | N/A |
#2 | $22.6M | 90 | 34% | N/A | N/A |
#3 | $92.1M | 367 | 20% | N/A | N/A |
#4 | $3.3M | 13 | 8% | N/A | N/A |
#5 | $2.8M | 11 | -8% | N/A | N/A |
#6 | $26.9M | 107 | 9% | N/A | N/A |
#7 | $14.1M | 56 | 22% | N/A | N/A |
#8 | $7.8M | 31 | 7% | N/A | N/A |
#9 | $9.8M | 39 | -29% | N/A | N/A |
#10 | $78.8M | 251 | -7% | $271M | N/A |
What Is Synerfuse?
SynerFuse is long-term pain management without the use of addictive opioids. SynerFuse combines two FDA-approved technologies and synergistically fuses both in order to attack the problem of long-term, post-surgery, lower back pain, with a preemptive, drug-free pain management system. It's simple – and brilliant. SynerFuse.
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.8M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 11 | N/A | N/A |
#2 | $1M | 11 | N/A | N/A |
#3 | $1.4M | 11 | 0% | N/A |
#4 | $1.6M | 11 | 0% | N/A |
#5 | $1M | 11 | -21% | N/A |